S. Choi

发表

Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial

D. Kuban, S. McGuire, Andrew K. Lee, 2016, American journal of clinical oncology.

Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends

D. Kuban, S. McGuire, K. Hoffman, 2019, Cancer.

Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial.

D. Kuban, S. McGuire, K. Hoffman, 2019, International journal of radiation oncology, biology, physics.

Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?

D. Kuban, S. McGuire, Andrew K. Lee, 2011, International journal of radiation oncology, biology, physics.

Drug, Healthcare and Patient Safety Dovepress Efficacy and Safety of Gonadotropin-releasing Hormone Agonists Used in the Treatment of Prostate Cancer

Andrew K. Lee, Seungtaek L. Choi, S. Choi, 2022 .

Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.

Michael J. Zelefsky, Thomas W. Feeley, Peter F. Orio, 2015, Brachytherapy.

Genitourinary Oncology Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing

D. Kuban, L. Potters, M. Zelefsky, 2016 .

A Prostate Fossa Contouring Instructional Module: Implementation and Evaluation.

C. Fuller, Seungtaek L. Choi, D. Golden, 2016, Journal of the American College of Radiology : JACR.

Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncology.

Arvind Rao, Todd McNutt, Clifton D Fuller, 2018, Medical physics.

Increased frequency of Mesorectal and Perirectal LN involvement in T4 Prostate Cancers.

D. Kuban, S. McGuire, T. Bathala, 2020, International journal of radiation oncology, biology, physics.

Radiation therapy does not impact local complication rates after free flap reconstruction for head and neck cancer.

Seungtaek L. Choi, M. Austin-Seymour, D. Schwartz, 2004, Archives of otolaryngology--head & neck surgery.

Improvement in Prostate Cancer Survival Over Time: A 20-Year Analysis

D. Kuban, S. McGuire, Andrew K. Lee, 2012, Cancer journal.

Baseline and longitudinal plasma caveolin‐1 level as a biomarker in active surveillance for early‐stage prostate cancer

S. Hanash, D. Kuban, P. Troncoso, 2018, BJU international.

Clinical Investigation : Genitourinary Cancer PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era

D. Kuban, S. McGuire, Andrew K. Lee, 2022 .

Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer.

D. Kuban, S. McGuire, Andrew K. Lee, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Investigation : Genitourinary Cancer Risk of Late Toxicity in Men Receiving Dose-Escalated Hypofractionated Intensity Modulated Prostate Radiation Therapy : Results From a Randomized Trial

D. Kuban, S. McGuire, Andrew K. Lee, 2014 .

Stability of MRI contrast agents in high-energy radiation of a 1.5 T MR-linac.

Jinzhong Yang, S. Vedam, Y. Mackeyev, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?

D. Kuban, Andrew K. Lee, L. Levy, 2008, International journal of radiation oncology, biology, physics.

Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic.

D. Kuban, Andrew K. Lee, K. Hoffman, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Online adaptive planning for prostate stereotactic body radiotherapy using a 1.5 Tesla magnetic resonance imaging-guided linear accelerator

Jinzhong Yang, S. Vedam, Seungtaek L. Choi, 2020, Physics and imaging in radiation oncology.

Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial

D. Kuban, S. McGuire, Andrew K. Lee, 2017, Advances in radiation oncology.

Integration of Radiation Therapy and Systemic Therapy for Breast Cancer

T. Buchholz, H. Thames, Seungtaek L. Choi, 2006 .

Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center

W. Woodward, A. Koong, M. McAleer, 2020, Advances in radiation oncology.

Strategies to Flatten the Curve during the COVID-19 Pandemic in Radiation Oncology: Experience from a Large Tertiary Cancer Center

W. Woodward, A. Koong, M. McAleer, 2020, Advances in Radiation Oncology.

Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial.

E. Jonasch, R. Murthy, Haesun Choi, 2021, The Lancet. Oncology.

Proton therapy for prostate cancer

Q. Nguyen, S. Choi, 2021, Proton Therapy.

Proton therapy for the treatment of prostate cancer

Seungtaek L. Choi, S. Choi, 2011 .

Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes.

D. Kuban, S. McGuire, K. Hoffman, 2018, International journal of radiation oncology, biology, physics.

Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer

D. Kuban, K. Hess, S. McGuire, 2020, JAMA network open.

Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable‐risk prostate cancer undergoing active surveillance

D. Kuban, Andrew K. Lee, K. Hoffman, 2016, BJU international.

Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer.

Jing Jiang, Benjamin D. Smith, K. Hoffman, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?

D. Kuban, S. McGuire, Andrew K. Lee, 2012, European journal of cancer.

Treatment Margins Predict Biochemical Outcomes After Prostate Brachytherapy

W. Cavanagh, K. Wallner, W. Butler, 2004, Cancer journal.

A single-field integrated boost treatment planning technique for spot scanning proton therapy

Xiaodong Zhang, Andrew K. Lee, T. Pugh, 2014, Radiation oncology.

Patient-specific quality assurance for prostate cancer patients receiving spot scanning proton therapy using single-field uniform dose.

Bijan Arjomandy, Xiaofei Song, Narayan Sahoo, 2011, International journal of radiation oncology, biology, physics.

The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer

D. Kuban, S. McGuire, Andrew K. Lee, 2012, American journal of clinical oncology.

Implementation and Assessment of an Informal Virtual Elective for Medical Student Radiation Oncology Exploration During the COVID19 Pandemic: a Brief Report

E. Holliday, A. Koong, P. Das, 2022, Journal of Cancer Education.

Consensus Statement on Proton Therapy for Prostate Cancer

J. Liao, W. Mendenhall, N. Vapiwala, 2021, International journal of particle therapy.

Salvaging failed radiation therapy: does the tumour location permit a less toxic approach?

John W. Davis, S. Choi, 2013, BJU International.

Local recurrence map to guide target volume delineation after radical prostatectomy.

D. Kuban, S. McGuire, K. Hoffman, 2014, Practical radiation oncology.

Preliminary Report of a Randomized Dose Escalation Trial for Prostate Cancer using Hypofractionation

D. Kuban, S. McGuire, Andrew K. Lee, 2010 .

Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy.

D. Kuban, S. McGuire, T. Bathala, 2020, Brachytherapy.

Magnetic Resonance-Guided Adaptive Radiotherapy for Prostate Cancer: The First Results from the MOMENTUM study, an International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiotherapy.

H. Verkooijen, J. Christodouleas, A. Choudhury, 2022, Practical radiation oncology.

Outcomes after adjuvant radiation therapy for prostate cancer at a comprehensive cancer center

D. Kuban, E. Holliday, S. McGuire, 2016, Journal of Radiation Oncology.

Long-term tumor control after brachytherapy for base-of-prostate cancer

D. Kuban, Andrew K. Lee, T. Pugh, 2011, Journal of contemporary brachytherapy.

Proton beam therapy for the treatment of prostate cancer.

Andrew K. Lee, T. Pugh, M. Gillin, 2013, Practical radiation oncology.

Quantification of prostate and seminal vesicle interfraction variation during IMRT.

Steven J Frank, Rajat J Kudchadker, Lei Dong, 2008, International journal of radiation oncology, biology, physics.

Quality of life after brachytherapy or bilateral nerve‐sparing robot‐assisted radical prostatectomy for prostate cancer: a prospective cohort

D. Kuban, S. McGuire, K. Hoffman, 2018, BJU international.

Determining Clinically-Based Factors Associated with Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort.

D. Kuban, P. Troncoso, R. Babaian, 2019, Urology.

MR imaging of prostate cancer in radiation oncology: what radiologists need to know.

Steven J Frank, Jingfei Ma, Harmeet Kaur, 2013, Radiographics : a review publication of the Radiological Society of North America, Inc.

Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.

Lei Dong, D. Kuban, S. McGuire, 2013, International journal of radiation oncology, biology, physics.

Dosimetric changes resulting from patient rotational setup errors in proton therapy prostate plans.

Andrew K. Lee, L. Levy, S. Sejpal, 2009, International journal of radiation oncology, biology, physics.